Tags: muscular dystrophyduchenne muscular dystrophyPTCfatweight gain
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
2 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | ||
3 | Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA | Givinostat Slows Duchenne Muscular Dystrophy Decline - 6 months ago | |
4 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | ||
5 | PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom | ||
6 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | In a Duchenne market beset by problems, Capricor data marks a bright spot - about 2 months ago | |
7 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | ||
8 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | Pfizer & Sarepta Gene Therapies Both Failed Phase 3, But Analysts Expect Sarepta Will Win Approval - 3 months ago | |
9 | Jason Mast STAT News Writing about science, medicine. | STAT+: Avidity Biosciences says its experimental drug showed potential against form of muscular dystrophy - 3 months ago STAT+: Duchenne muscular dystrophy drug from Nippon Shinyaku fails in rare confirmatory trial - 4 months ago | |
10 | Hannah Thomasy, PhD The Scientist Freelance science writer. PhD. Seattle & Toronto | Obesity Research is Going to the Dogs - 4 months ago |